<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ozuynuk-Ertugrul AS</submitter><funding>Scientific Research Projects Coordination Unit of Istanbul University</funding><pagination>361-372</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11064099</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Increasing mortality and morbidity of coronary artery disease (CAD) highlight the emerging need for novel noninvasive markers such as circulating microRNAs (miRNAs).&lt;h4>Objective&lt;/h4>To evaluate the circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326, and their associations with known contributors to CAD, in CAD subgroups.&lt;h4>Methods&lt;/h4>We divided the cohort into 4 groups: non-CAD controls (≤30% stenosis; n = 55), and patients with stable angina pectoris (SAP; n = 48), unstable AP (UAP; n = 46), and myocardial infarction (MI; n = 36). The circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326 were determined using TaqMan Advanced miRNA Assays in serum specimens.&lt;h4>Results&lt;/h4>Circulating miR-126-3p levels were lower in the MI and UAP grou</pubmed_abstract><journal>Laboratory medicine</journal><pubmed_title>Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.</pubmed_title><pmcid>PMC11064099</pmcid><funding_grant_id>28984</funding_grant_id><funding_grant_id>37688</funding_grant_id><pubmed_authors>Ekici B</pubmed_authors><pubmed_authors>Ozuynuk-Ertugrul AS</pubmed_authors><pubmed_authors>Erkan AF</pubmed_authors><pubmed_authors>Coban N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.</name><description>&lt;h4>Background&lt;/h4>Increasing mortality and morbidity of coronary artery disease (CAD) highlight the emerging need for novel noninvasive markers such as circulating microRNAs (miRNAs).&lt;h4>Objective&lt;/h4>To evaluate the circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326, and their associations with known contributors to CAD, in CAD subgroups.&lt;h4>Methods&lt;/h4>We divided the cohort into 4 groups: non-CAD controls (≤30% stenosis; n = 55), and patients with stable angina pectoris (SAP; n = 48), unstable AP (UAP; n = 46), and myocardial infarction (MI; n = 36). The circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326 were determined using TaqMan Advanced miRNA Assays in serum specimens.&lt;h4>Results&lt;/h4>Circulating miR-126-3p levels were lower in the MI and UAP grou</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-08T23:13:34.891Z</modification><creation>2026-04-07T13:17:59.834Z</creation></dates><accession>S-EPMC11064099</accession><cross_references><pubmed>38048807</pubmed><doi>10.1093/labmed/lmad094</doi></cross_references></HashMap>